Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on May 28, 2025
Benevis Celebrates Decade-Long Impact of Delivering Free Dental Care to Over 3,800 Uninsured Children and Adults During Sharing Smiles Day
GlobeNewswire
·
May 28, 2025
Atlanta, GA, May 28, 2025 (GLOBE NEWSWIRE) -- Benevis is proud to share that over the course of the last 10 years, company volunteers have positively impacted the oral health of more than 3,800 uninsured and underinsured patients during Sharing Smiles Day. …
Calgary refugees have their healthcare services saved temporarily thanks to Calgary Health Foundation donors
GlobeNewswire
·
May 28, 2025
Calgary, Alberta, Canada, May 28, 2025 (GLOBE NEWSWIRE) -- Calgary Health Foundation is proud to announce a commitment to the Calgary Refugee Health Clinic, one that will secure its operations for the next two years. The $550K promise, made possible thanks …
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3
GlobeNewswire
·
May 28, 2025
HOUSTON, TX, May 28, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on June 3, 2025, at 4:15 p.m. ET. Attendees will gain an inside look at Nexalin’s game- …
Local Neurosurgeon Jeremy Denning Raises Awareness for National Scoliosis Month
GlobeNewswire
·
May 28, 2025
PLANO, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- June is National Scoliosis Awareness Month – an ideal time to explore causes and treatment methods for scoliosis, which affects approximately 7 million people in the United States, as reported by the National …
Intrommune Therapeutics Announces Independent Editorial Highlighting Breakthrough Safety Data for Novel Toothpaste Peanut Allergy Treatment
GlobeNewswire
·
May 28, 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- As the burden of food allergies continues to increase each year, the need for safe, effective, and convenient treatments has never been greater. Over 33 million Americans suffer from food allergies, including …
AI GPO Launches as Nation’s First AI-Focused Group Purchasing Organization, Democratizing Advanced AI Technology and Essential Business Savings
GlobeNewswire
·
May 28, 2025
ROCHESTER, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- AI GPO, the world’s first Group Purchasing Organization (GPO) singularly focused on Artificial Intelligence, today announced its national launch. The company is set to democratize access to the latest AI …
Aclaris Therapeutics to Participate in Two June Healthcare Conferences
GlobeNewswire
·
May 28, 2025
WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will …
BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements
GlobeNewswire
·
May 28, 2025
LAS VEGAS, May 28, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), through its pets division PawPa™, a leader in premium pet wellness, proudly announces the remarkable stem cell benefits of its flagship product, Regen Dog Chews, …
Olympia Pharmaceuticals Secures $637,000 Workforce Training Grant to Boost Job Creation in Orlando
GlobeNewswire
·
May 28, 2025
ORLANDO, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, a leading innovator in the pharmaceutical industry, is proud to announce it has secured $637,500 in workforce training funds to support the continued expansion of its sister brand, …
Marius Pharmaceuticals Receives Sixth U.S. Patent Allowance for KYZATREX® (testosterone undecanoate) CIII Capsules Extending Coverage to 2040
GlobeNewswire
·
May 28, 2025
RALEIGH, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, announced today that the United States Patent and Trademark Office (USPTO) for a new …
Distalmotion Gains FDA 510(k) Clearance for Cholecystectomy, Further Advancing Access to Robotics in the Outpatient Setting with its DEXTER® Robotic Surgery System
GlobeNewswire
·
May 28, 2025
Lausanne, Switzerland, May 28, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in more sites of care, today announced that it has received FDA 510(k) clearance for the use of its DEXTER …
Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada
GlobeNewswire
·
May 28, 2025
TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is proud to award $85,000 to a groundbreaking research project led by Dr. Sheila Singh and her team at McMaster University. The project titled "Lamin B Receptor (LBR) as an Immunotherapeutic …
Connect Biopharma to Present at Two Upcoming Investor Conferences in June
GlobeNewswire
·
May 28, 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic …
Flare Therapeutics to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that the …
HCVC leads kyron.bio €5.5M round to use glycan engineering for advanced drug design
GlobeNewswire
·
May 28, 2025
Paris, May 28, 2025 (GLOBE NEWSWIRE) -- One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects. Biotechnology company kyron.bio today announced a €5.5 million funding round to solve these issues …
Alpha Tau to Present at Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
JERUSALEM, May 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present at the …
Vittoria Biotherapeutics to Share Trials-in-Progress Presentation from Phase 1 Study of VIPER-101 at ASCO 2025 Annual Meeting
GlobeNewswire
·
May 28, 2025
PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics Inc., a clinical-stage immunotherapy company specializing in the development of innovative therapies for hard-to-treat diseases, today announced it will present a trials-in-progress …
iTeos Therapeutics Announces Its Intention to Wind Down Operations
GlobeNewswire
·
May 28, 2025
- Board of Directors intends to cease operations - Company to focus efforts on selecting best path to deliver near-term value to shareholders - Exploring potential asset sales including EOS-984, EOS-215, and a preclinical obesity program targeting ENT1 …
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
GlobeNewswire
·
May 28, 2025
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold Resumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M milestone due in six months; as previously disclosed GSK …
Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that new data will be presented at the American Society …